SEC Form 4 · accession 0001209191-18-018361
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pat Cotroneo
Officer — VP, Finance and CFO
Period of report
Mar 6, 2018
Accepted (ET)
Mar 8, 2018 · 8:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 6, 2018 | F | 5,832 | $53.55 | D | 176,160 | D | |
| Common StockF2,F3 | Mar 8, 2018 | S | 906 | $52.68 | D | 175,254 | D | |
| Common StockF2,F4 | Mar 8, 2018 | S | 909 | $53.45 | D | 174,345 | D | |
| Common StockF2,F5 | Mar 8, 2018 | S | 79 | $54.47 | D | 174,266 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
- F2Shares sold pursuant to a 10b5-1 plan.
- F3The shares were sold at prices ranging from $52.10 to $53.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The shares were sold at prices ranging from $53.10 to $53.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The shares were sold at prices ranging from $54.10 to $54.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.